IDXG

Interpace Biosciences, Inc. IDXG

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode IDXG HTGMQ BIAF PRPO PULM GLBS GYRE
6M -27.68 % 0.00 % -83.58 % 235.69 % -7.79 % 2.66 % 10.49 %
YTD -63.16 % 0.00 % -90.57 % 254.48 % -34.91 % -5.75 % -30.76 %
1Y -50.94 % -66.67 % -95.26 % 195.49 % 135.98 % -34.67 % -37.72 %
3Y -48.34 % -99.98 % -96.67 % 12.83 % 43.90 % -18.45 % -6.12 %
5Y -67.24 % -100.00 % -98.93 % -57.40 % -78.90 % -91.79 % -88.44 %
10Y -99.36 % -100.00 % -98.93 % -99.30 % -99.41 % -99.97 % -99.33 %
From the beginning -99.95 % -100.00 % -98.93 % -99.30 % -99.86 % -100.00 % -99.94 %

Dividend

Globus Maritime Limited

Gyre Therapeutics, Inc.